Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05996003
PHASE2

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

Sponsor: NS Pharma, Inc.

View on ClinicalTrials.gov

Summary

This is a Phase 2, open-label, multi-center, 2-part study of NS-089/NCNP-02 administered by weekly IV infusion to ambulant boys aged ≥4 to \<15 years with DMD due to mutations amenable to exon 44 skipping. Participants will receive a selected dose of NS-089/NCNP-02 administered once weekly. The study consists of 2 parts: Part 1 and Part 2. Six participants (Cohort 1) will participate in both Part 1 and Part 2, and 14 participants (Cohort 2) will be added for Part 2.

Official title: A Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NS-089/NCNP-02 in Boys With Duchenne Muscular Dystrophy (DMD)

Key Details

Gender

MALE

Age Range

4 Years - 14 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2024-02-22

Completion Date

2026-09-11

Last Updated

2026-03-06

Healthy Volunteers

No

Interventions

DRUG

NS-089/NCNP-02

Cohort 1: Part 1 Dose Level 1-3: a 4-week Treatment Phase at each treatment dose level Part 2 Single Dose Level: a 24-week Treatment Phase at the MTD of Part 1 Cohort 2: Part 2 Single Dose Level: a 24-week Treatment Phase at the MTD of Part 1

Locations (25)

Children's Hospital Colorado

Aurora, Colorado, United States

Rare Disease Research, LLC - FL

Kissimmee, Florida, United States

Rare Disease Research

Atlanta, Georgia, United States

Ann and Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

University of Kansas Medical Center (KUMC)

Kansas City, Kansas, United States

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

The Children's Hospital of Philadelphia (CHOP)

Philadelphia, Pennsylvania, United States

University of Pittsburgh School of Medicine

Pittsburgh, Pennsylvania, United States

UT Southwestern/Children's Health

Dallas, Texas, United States

Virginia Commonwealth University Health System

Richmond, Virginia, United States

Perth Children's Hospital

Nedlands, Western Australia, Australia

Alberta Children's Hospital

Calgary, Alberta, Canada

British Columbia Children's Hospital

Vancouver, British Columbia, Canada

London Health Sciences Centre

London, Ontario, Canada

Fukui Prefectural Hospital

Fukui-shi, Fukui, Japan

National Hospital Organization Nagara Medical Center

Nagara, Gifu-shi, Gifu, Japan

NHO Osaka Toneyama Medical Center

Toyonaka, Osaka, Japan

Shiga General Hospital

Moriyama-shi, Shiga, Japan

National Center of Neurology and Psychiatry

Kodaira, Tokyo, Japan

Starship Children's Hospital

Auckland, New Zealand

Pusan National University Yangsan Hospital

Yangsan, Gyeongsangnam, South Korea

Seoul National University Hospital

Seoul, South Korea

Ankara Bilkent City Hospital

Ankara, Turkey (Türkiye)

Yeditepe University Kosuyolu Hospital

Istanbul, Turkey (Türkiye)

S.B.U. Dr. Behcet uz Pediatric Diseases and Surgery Training and Research Hospital

Izmir, Turkey (Türkiye)